首页> 中文期刊>中国天然药物 >Systems pharmacology-based investigation of Sanwei Ganjiang Prescription: related mechanisms in liver injury

Systems pharmacology-based investigation of Sanwei Ganjiang Prescription: related mechanisms in liver injury

     

摘要

Liver injury remains a significant global health problem and has a variety of causes,including oxidative stress (OS),inflammation,and apoptosis of liver cells.There is currently no curative therapy for this disorder.Sanwei Ganjiang Prescription (SWGJP),derived from traditional Chinese medicine (TCM),has shown its effectiveness in long-term liver damage therapy,although the underlying molecular mechanisms are still not fully understood.To explore the underlining mechanisms of action for SWGJP in liver injury from a holistic view,in the present study,a systems pharmacology approach was developed,which involved drug target identification and multilevel data integration analysis.Using a comprehensive systems approach,we identified 43 candidate compounds in SWGJP and 408 corresponding potential targets.We further deciphered the mechanisms of SWGJP in treating liver injury,including compound-target network analysis,target-function network analysis,and integrated pathways analysis.We deduced that SWGJP may protect hepatocytes through several functional modules involved in liver injury integrated-pathway,such as Nrf2-dependent anti-oxidative stress module.Notably,systems pharmacology provides an alternative way to investigate the complex action mode of TCM.

著录项

  • 来源
    《中国天然药物》|2018年第10期|756-765|共10页
  • 作者单位

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Cancer Center, Sun Yat-sen University, Guangzhou 510060, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China;

    School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 实验药理学;
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号